Emma Cummins
FPInnovations(CA)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Peptidase Inhibition and Analysis, T-cell and B-cell Immunology, Cell Adhesion Molecules Research, Immune Cell Function and Interaction
Most-Cited Works
- → Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer(2016)94 cited
- → Cell-surface proteomics for the identification of novel therapeutic targets in cancer(2018)86 cited
- → Fundamental Characteristics of the Immunoglobulin VH Repertoire of Chickens in Comparison with Those of Humans, Mice, and Camelids(2011)85 cited
- → Affinity Maturation of a Humanized Rat Antibody for Anti-RAGE Therapy: Comprehensive Mutagenesis Reveals a High Level of Mutational Plasticity Both Inside and Outside the Complementarity-Determining Regions(2009)63 cited
- → CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous delivery(2013)33 cited
- → A simple high-throughput purification method for hit identification in protein screening(2008)20 cited
- → Anti-ICOSL New Antigen Receptor Domains Inhibit T Cell Proliferation and Reduce the Development of Inflammation in the Collagen-Induced Mouse Model of Rheumatoid Arthritis(2018)12 cited
- → Human Fc gamma receptor IIIA blockade inhibits platelet destruction in a humanized murine model of ITP(2024)8 cited
- → Abstract 6028: Preferential tumor-to-normal tissue biodistribution and single-dose efficacy with ABD147, a DLL3-targeted engineered antibody-based radiotherapeutic, in preclinical small cell lung cancer models(2024)2 cited
- → Abstract 580: 111In/225Ac-ABD320, a novel 5T4-targeted radiopharmaceutical with favorable tumor-to-normal tissue biodistribution and single-dose efficacy in preclinical cancer models(2025)